| Title |
Randomized Polypill Crossover Trial in People Aged 50 and Over
|
|---|---|
| Published in |
PLOS ONE, July 2012
|
| DOI | 10.1371/journal.pone.0041297 |
| Pubmed ID | |
| Authors |
David S. Wald, Joan K. Morris, Nicholas J. Wald |
| Abstract |
A Polypill is proposed for the primary prevention of cardiovascular disease in people judged to be at risk on account of their age alone. Its efficacy in reducing cholesterol and blood pressure is uncertain. |
X Demographics
The data shown below were collected from the profiles of 44 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 13 | 30% |
| United States | 4 | 9% |
| Spain | 3 | 7% |
| Germany | 2 | 5% |
| Japan | 1 | 2% |
| Mexico | 1 | 2% |
| Jersey | 1 | 2% |
| Argentina | 1 | 2% |
| Canada | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 16 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 59% |
| Scientists | 9 | 20% |
| Practitioners (doctors, other healthcare professionals) | 6 | 14% |
| Science communicators (journalists, bloggers, editors) | 3 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| Germany | 1 | <1% |
| Malaysia | 1 | <1% |
| New Zealand | 1 | <1% |
| Mexico | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 125 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 16% |
| Student > Ph. D. Student | 20 | 15% |
| Researcher | 14 | 10% |
| Student > Master | 11 | 8% |
| Other | 8 | 6% |
| Other | 28 | 21% |
| Unknown | 32 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 37% |
| Agricultural and Biological Sciences | 14 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 7% |
| Nursing and Health Professions | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 17 | 13% |
| Unknown | 35 | 26% |